Back to All
April 1, 2020

PyrAmes Awarded SBIR Phase I Grant from NIH

PyrAmes is pleased to announce it has been awarded a Phase I grant from the National Institutes of Health. The Grant will be used for ongoing product development as well as clinical validation studies. A key objective of the NIH Grant Program is to facilitate development of promising medical technologies. The content of this announcement is solely the responsibility of the author and does not necessarily represent the official views of the NIH.